Health Canada approves obesity drug Wegovy

Wegovy is a weight-loss drug. Health Canada says it can now be used to curb heart-attack risk
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults
Health Canada approves Novo Nordisk’s Wegovy to cut heart attacks
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/90.BMDkfsfZ.js
Wegovy approved in Canada to combat risk of non fatal-heart attack
Health Canada has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults.
Health Canada approves Wegovy® (semaglutide injection) to reduce the risk of non-fatal myocardial infarction
Novo Nordisk announced today that Wegovy® (semaglutide injection) is now approved to reduce the risk of non-fatal myocardial infarction in adults with established cardiovascular disease and BMI equal to or greater than 27 kg/m2.
Health Canada approves obesity drug Wegovy as a way to reduce risk of non-fatal heart attack
Canada's health regulator has approved Novo Nordisk's weight-loss drug Wegovy to reduce the risk of nonfatal heart attack or myocardial infarction in some adults
Health Matters: Wegovy approved to reduce heart attack risk
Novo Nordisk says Health Canada has approved its weight loss drug Wegovy to reduce the risk of heart attacks in some adults. Kyle Benning has the details and more in Health Matters for Nov. 27, 2024.
Why some people don’t lose weight with Wegovy
Clinical trials show that around one in ten people are ‘non-responders’. Outside of trials, that figure might be much higher.
More organic carrots are recalled in Canada over E.coli outbreak
The Canadian Food Inspection Agency (CFIA) has expanded its recall of organic baby and full-size carrots due to potential E.
Wegovy costs $1,349 in the US vs. $92 in the UK. Why are weight loss drugs so pricey?
About 42% of U.S. adults are obese, the CDC says. GLP-1 medications have changed the picture for people hoping to reduce ...
The Economist8h
Wegovy hits the People’s Republic, at last
But for a long time China’s people struggled to get hold of Wegovy because the country’s regulators had not approved it. Some ...
Novo Nordisk sells hit weight-loss drug in China—at fraction of US price
Patients in China will be able to purchase the blockbuster weight-loss drug Wegovy for 1,400 yuan, or about $193, just a ...
Drugs like Wegovy, Ozempic would be covered by Medicare, Medicaid under Biden proposal
Millions of Americans would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare and ...
Voice Online1d
Health Canada approves Wegovy (semaglutide injection) to reduce risk of non-fatal myocardial infarction
NOVO Nordisk on Wednesday announced that Wegovy (semaglutide injection) is now approved to reduce the risk of non-fatal ...